Unlike their logistics-driven counterparts in the US, European hospital supply distributors have stressed their role as exclusive sales agents for selected manufacturers. But in Germany, cost pressures are forcing hospitals to look at process as much as product, leading suppliers like Krauth into an array of service-oriented, asset management-based businesses.
by David Cassak
Traditionally, US and European hospital supply distributors have taken very different paths toward the same goal: arguing for the value...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.
While the adoption of most favored nation drug pricing in the US stands to affect Japanese biopharma firms now heavily reliant on this market, it might also present an opportunity for pricing and policy reforms at home.
